Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.71 EUR | -0.39% | -2.90% | -.--% |
2014 | Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara | RE |
2013 | Elan Corporation, plc : Ex-SAC manager Martoma fails to end part of insider case | RE |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |
- Stock Market
- Equities
- DRX Stock
- Charts Elan Corporation Ltd
- Sector Chart